NZ596017A - Ionophore antibiotic veterinary composition and method of manufacture - Google Patents

Ionophore antibiotic veterinary composition and method of manufacture

Info

Publication number
NZ596017A
NZ596017A NZ596017A NZ59601711A NZ596017A NZ 596017 A NZ596017 A NZ 596017A NZ 596017 A NZ596017 A NZ 596017A NZ 59601711 A NZ59601711 A NZ 59601711A NZ 596017 A NZ596017 A NZ 596017A
Authority
NZ
New Zealand
Prior art keywords
ionophore antibiotic
manufacture
composition
veterinary composition
ionophore
Prior art date
Application number
NZ596017A
Inventor
John Morley Munro
Raymond Nigel Simms
Kin-Wai Mok
Original Assignee
Glenmark Ip Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Ip Ltd filed Critical Glenmark Ip Ltd
Priority to NZ596017A priority Critical patent/NZ596017A/en
Priority to PCT/NZ2012/000196 priority patent/WO2013062425A1/en
Publication of NZ596017A publication Critical patent/NZ596017A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Abstract

596017 Disclosed herein is a water dispersible granule ionophore antibiotic composition, said composition comprising: from 5 to 80% w/w of at least one ionophore antibiotic; from 10 to 90% w/w of at least one filler-binder; from 0.1 to 20% w/w of at least one surfactant; from 0.1 to 20% w/w of at least one dispersing agent; and from 0.1 to 30% of at least one disintegrant; and a method of preparing said composition. Additionally disclosed is a method of prociding an ionophore antibiotic to a non-human animal, said method comprising directly or indirectly adding an effective amount of the water dispersible granule to the drinking water of said animal.
NZ596017A 2011-10-26 2011-10-26 Ionophore antibiotic veterinary composition and method of manufacture NZ596017A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NZ596017A NZ596017A (en) 2011-10-26 2011-10-26 Ionophore antibiotic veterinary composition and method of manufacture
PCT/NZ2012/000196 WO2013062425A1 (en) 2011-10-26 2012-10-25 Ionophore antibiotic veterinary composition and method of manufacture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ596017A NZ596017A (en) 2011-10-26 2011-10-26 Ionophore antibiotic veterinary composition and method of manufacture

Publications (1)

Publication Number Publication Date
NZ596017A true NZ596017A (en) 2014-04-30

Family

ID=48168135

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ596017A NZ596017A (en) 2011-10-26 2011-10-26 Ionophore antibiotic veterinary composition and method of manufacture

Country Status (2)

Country Link
NZ (1) NZ596017A (en)
WO (1) WO2013062425A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016176121A1 (en) 2015-04-28 2016-11-03 Eli Lilly And Company Monensin water dispersible granules by wet granulation

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018187849A1 (en) * 2017-04-13 2018-10-18 Pharmako Biotechnologies Pty Limited Cold-water-dispersible chemical delivery system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ280384A (en) * 1995-11-02 1997-01-29 Lilly Eli & Co Nz Ltd Animal feed supplement comprising a wettable powder composition of an ionophore antibiotic
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
WO2010038237A2 (en) * 2008-09-22 2010-04-08 Rubicon Research Private Limited Compositions exhibiting delayed transit through the gastrointestinal tract

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016176121A1 (en) 2015-04-28 2016-11-03 Eli Lilly And Company Monensin water dispersible granules by wet granulation

Also Published As

Publication number Publication date
WO2013062425A1 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
PH12016502092A1 (en) Antimicrobial compounds and methods of making and using the same
MY176900A (en) Antimicrobial compounds and methods of making and using the same
MY173518A (en) Antimicrobial compounds and methods of making and using the same
IN2015DN01951A (en)
PH12015502375A1 (en) Antimicrobial compounds and methods of making and using the same
WO2011143358A3 (en) Method for lowering ph using urea sulfate in the presence of corrosion inhibitor
MY174917A (en) Antibacterial microelement chelates and the use thereof in animal feeds
UA114402C2 (en) Stabilized biocontrol water dispersible granules
MX2012007541A (en) Fungicide hydroximoyl-heterocycles derivatives.
MY161870A (en) Antimicrobial compounds and methods of making and using the same
MX336369B (en) Use of ellagic acid as an anti-dandruff agent.
NZ596017A (en) Ionophore antibiotic veterinary composition and method of manufacture
MY166384A (en) Fungicidal aqueous suspension composition for agriculture and horticulture
MX2013013417A (en) Fabric cleaning composition comprising hueing agent.
UA109460C2 (en) N-hetarylmethyl pyrazolylcarboxamides
RU2009140526A (en) MEANS FOR PRE-SEEDING TREATMENT OF SEEDS OF AGRICULTURAL CROPS
FR2957225B1 (en) PROCESS FOR THE ELEVATION OF SHELLAGES, IN PARTICULAR OYSTERS
MX2017011549A (en) Archaebacteria in bioactive animal feed, method of making the composition and methods employing the composition.
CL2017002649A1 (en) Monensin granules dispersible in water by wet granulation.
MX342592B (en) Compositions of dibromomalonamide and their use as biocides.
MX2016013287A (en) Alkanolamine sulfate water conditioners.
WO2012170519A3 (en) Process for producing fertilizer from animal manure
Sherman et al. Exploration of fluid dynamic indicators/causative factors in the formation of tower structures in staphylococci bacteria bio-films
UA90019U (en) Method for improving productivity of young animals of fattening pigs
UA90021U (en) Method for improving productivity of young animals of pigs for growing purposes

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: GLENMARK IP LIMITED, NZ

Free format text: OLD OWNER(S): Q A DIAGNOSTICS LIMITED

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2017 BY PIPERS

Effective date: 20160725

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2018 BY PIPERS

Effective date: 20170922

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2019 BY PIPERS

Effective date: 20180927

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2020 BY PIPERS

Effective date: 20191015

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2021 BY PIPERS

Effective date: 20200831

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2022 BY PIPERS

Effective date: 20210824

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2023 BY PIPERS

Effective date: 20220930

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2024 BY PIPERS

Effective date: 20231002